Gossamer Bio Inc’s recent filing unveils that its Director Milligan Sandra acquired Company’s shares for reported $50016.0 on Aug 19 ’25. In the deal valued at $1.92 per share,26,050 shares were bought. As a result of this transaction, Milligan Sandra now holds 58,050 shares worth roughly $0.19 million.
UBS upgraded its Gossamer Bio Inc [GOSS] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid July with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering GOSS with “an Outperform” recommendation on June 25, 2024.
Price Performance Review of GOSS
On Tuesday, Gossamer Bio Inc [NASDAQ:GOSS] saw its stock fall -12.86% to $3.29. Over the last five days, the stock has lost -7.72%. Gossamer Bio Inc shares have risen nearly 290.65% since the year began. Nevertheless, the stocks have risen 263.14% over the past one year. While a 52-week high of $3.87 was reached on 12/15/25, a 52-week low of $0.76 was recorded on 04/09/25.
Levels Of Support And Resistance For GOSS Stock
The 24-hour chart illustrates a support level at 3.07, which if violated will result in even more drops to 2.86. On the upside, there is a resistance level at 3.63. A further resistance level may holdings at 3.98.
How much short interest is there in Gossamer Bio Inc?
A steep rise in short interest was recorded in Gossamer Bio Inc stocks on 2025-11-28, dropping by -1.48 million shares to a total of 23.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 24.92 million shares. There was a decline of -6.31%, which implies that there is a negative sentiment for the stock.
